China Suntien Green Energy Corp Ltd (600956)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 7.010 |
|---|---|
| 52-week range | 6.600 – 11.240 |
| Return, 1 month / 3 months | −4.8% / −1.1% |
| Return, 1 year / 3 years | −7.4% / −17.3% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 37.5% |
| Worst drawdown (1 year) | -36.9% |
| Average daily value traded | 56.02M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
China Suntien Green Energy is a Chinese energy company based in Hebei province that develops and operates wind and solar power generation facilities, supplying electricity to regional grids. It also runs a natural gas business, distributing gas through city networks and pipelines to industrial, commercial and residential customers. The company combines renewable power production with gas distribution, serving energy demand in northern China through these two main segments.
China Suntien Green Energy Corp Ltd trades under the code 600956 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
China Suntien Green Energy Corp Ltd (600956) trades on the Shanghai Stock Exchange in China. It last closed at CNY 7.010 on 19 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 935 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.4% and over the last three months it fell 1.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 55 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -10.5% | ||
| From 52-week high | -34.6% | ||
| Momentum | 57 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -1.1% | ||
| 6-month return | -12.4% | ||
| 12-month return, skipping the last month | -2.8% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 37.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.9% | ||
| Liquidity | 25 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 56.02M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −4.8% |
| 3 months | −1.1% |
| 6 months | −12.4% |
| 1 year | −7.4% |
| 3 years | −17.3% |
| 5 years | – |
Signals
| 50-day / 200-day average | 7.176 / 7.830 |
|---|---|
| Golden / death cross (60 days) | Death, 58 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.161 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Jun 2023 | CNY 0.1930 |
| 21 Jul 2022 | CNY 0.1670 |
| 9 Jun 2021 | CNY 0.1360 |
| 2 Nov 2020 | CNY 0.1250 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.